Tirzepatide Structure: Dual GIP/GLP-1 Agonist Molecular Architecture
Tirzepatide's molecular architecture — built on non-natural amino acid substitutions, a C20 fatty diacid tether, and strategic receptor bias — represents the structural blueprint that enabled the leap from single to dual and ultimately triple receptor agonism in metabolic peptide research.